Eleanor M. Scott
Roosevelt Drive
Oxford, ENG, United Kingdom
Oxford, ENG, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
Oncolytic herpesvirus expressing PD-L1 BiTE for cancer therapy: exploiting tumor immune suppression as an opportunity for targeted immunotherapy.
Journal: Journal for immunotherapy of cancer
Published: March 10, 2021
Use of Liquid Patient Ascites Fluids as a Preclinical Model for Oncolytic Virus Activity.
Journal: Methods in molecular biology (Clifton, N.J.)
Published: September 06, 2019
Bi- and tri-valent T cell engagers deplete tumour-associated macrophages in cancer patient samples.
Journal: Journal for immunotherapy of cancer
Published: June 12, 2019
Antagonism of Glycolysis and Reductive Carboxylation of Glutamine Potentiates Activity of Oncolytic Adenoviruses in Cancer Cells.
Journal: Cancer research
Published: May 09, 2018
Turning cold tumours hot: oncolytic virotherapy gets up close and personal with other therapeutics at the 11th Oncolytic Virus Conference.
Journal: Cancer gene therapy
Published: May 01, 2018
Oncolytic adenovirus expressing bispecific antibody targets T-cell cytotoxicity in cancer biopsies.
Journal: EMBO molecular medicine
Published: June 22, 2017
Solid Tumor Immunotherapy with T Cell Engager-Armed Oncolytic Viruses.
Journal: Macromolecular bioscience
Published: June 01, 2017
Overcoming Barriers in Oncolytic Virotherapy with HDAC Inhibitors and Immune Checkpoint Blockade.
Journal: Viruses
Published: September 30, 2015
Oncolytic parvoviruses: from basic virology to clinical applications.
Journal: Virology journal
Published: August 04, 2014
Showing 1-10 of 10
Last Updated: 09/26/2026